Introduction
Nitric oxide (NO) synthase converts L-arginine to NO and L-citrulline. Recent work characterizing this enzyme shows that there exist at least two forms in mammalian cells: a constitutive and Ca 2+ -dependent form which is typically found in endothelium and brain and a cytokine-induciblc, Ca 2+ -independent form which can be found in macrophages but also a variety of other cell types. NO stimulates guanylate cyclase and thus mediates vasodilation and its effects in neurotransmission. Via formation of iron nitrosyl complexes NO inhibits aconitase and ribonucleotide reductase, leading to cytotoxicity [for review on NO synthase see (1) ].
Both types of NO synthase require NADPH, flavins and tetrahydrobiopterin as cofactors and it was shown recently that FAD, FMN and tetrahydrobiopterin copurify with the enzyme from porcine cerebellum (2, see also Werner, E. R. et al., this volume).
Here we compare the effect of influencing intracellular tetrahydrobiopterin levels on cytokine-induced NO synthase from murine fibroblasts and on the constitutive NO synthase from human endothelial cells.
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Material and Methods
Murine fibroblasts isolated from ear dermis of Balb/c mice were cultured as described (3) . Human endothelial cells from umbilical vein were grown on gelatinecoated surfaces in medium 199 supplemented with 20% (v/v) of heat-inactivated fetal calf serum, 2 mM L-glutamine, 100 U/ml penicillin, 0.1 mg/ml streptomycin, 50 μg/ml endothelial cell growth supplement (Boehringer, FRG), 50 μg/ml insulin, 0.1 mg/ml transferrin and 0.5% (w/v) of bovine serum albumine. Cells used for experiments were between passage 3 and 12.
In murine fibroblasts formation of NO was determined as the amount of nitrite accumulated in supernatants after 48 to 72 hours of cytokine treatment (50 U/ml murine interferon-gamma in combination with 500 U/ml murine tumour necrosis factor-alpha). In endothelial cells NO was measured via formation of cGMP upon activation of constitutive NO synthase by the Ca-ionophore A23187. For this purpose endothelial cells grown in 6-well plates were treated for 15 min with 1 mM 3-isobutyl-l-methyl-xanthine in 10 mM Hepes, pH = 7.5, containing 145 mM NaCl, 5 mM KCl, 1 mM MgCl 2 and 2.5 mM CaCl 2 . The reaction was started by addition of 1 μΜ A23187. After 4 min the reaction mixture was removed and cGMP levels of individual wells were determined after cell lysis with 0.01 Ν HCl by radioimmunoassay (Amersham, UK).
Tetrahydrobiopterin synthesis was inhibited by treatment of cells with 5 mM 2,4-diamino-6-hydroxy-pyrimidine (DAHP) for 24 hours in endothelial cells and for the period of cytokine induction in murine fibro-blasts. For reconstitution of the cofactor, cells were treated with 100 μΜ sepiapterin (3). Determination of intracellular tetrahydrobiopterin levels was done by HPLC as described (3).
Results and Discussion
Murine fibroblasts formed 38.8 + 1.4 μηιοΙ/1 of nitrite upon treatment with interferon-gamma/tumour necrosis factor-alpha. By addition of sepiapterin (100 μΜ) this amount was increased to 57.9 + 2.9. Inhibition of GTP-cyclohydrolase I by DAHP decreased nitrite levels to 12.0 + 1.6, which was increased to 49.1 + 0.5, when sepiapterin was added concomitantly with DAHP. In parallel, intracellular tetrahydrobiopterin concentrations were decreased or increased by this treatment. Addition of 10 μΜ methotrexate in presence of DAHP and sepiapterin fully blocked formation of nitrite and reduced tetrahydrobiopterin levels to control values (3).
Thus, we could demonstrate in murine fibroblasts that the intracellular concentration of tetrahydrobiopterin modulates the amount of nitrite formed upon cytokine treatment.
Human cells thus far failed to be induced for NO synthesis by cytokines in vitro. However, these cells express constitutive, Ca 2+ -dependent NO synthase which also uses tetrahydrobiopterin as a cofactor (4) . Applying the same strategy as with murine fibroblasts, we found that DAHP inhibited NO synthase in a dose-dependent manner, whereas increasing sepiapterin doses constantly increased the activity of NO synthase (see Fig. 1 ). Like in murine fibroblasts, the effects of DAHP could be fully restored by concomitant addition of sepiapterin. Interestingly, endothelial cells from porcine aortae did not show an increase of NO synthase activity with addition of 100 μΜ sepiapterin (5) . This suggests that in contrast to human endothelial cells NO synthase of porcine endothelial cells is saturated with the cofactor.
Treatment with interferon-gamma alone or in combination with interleukin-lß leads to induction of GTP-cyclohydrolase I in endothelial cells. This cytokine-induced increase of intracellular tetrahydrobio- pterin levels also leads to an increased turnover of NO synthase resulting in elevation of cGMP levels by 56 + 13%. Thus, both forms of NO synthase, i.e. the cytokine-inducible enzyme found in rodent cells as well as the constitutive form found in human endothelial cells, can be modulated via intracellular levels of tetrahydrobiopterin, the synthesis of which is induced by cytokines in either case.
